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Clinical StudyAltered Editing of Serotonin 2C
Receptor Pre-mRNA in the Prefrontal
Cortex of Depressed Suicide Victims
tials of three triplet codons. Editing at the A and A/B
site(s) converts an isoleucine to a valine (I/V), and editing
at the B site generates a methionine at this site. Editing
at the C site converts an asparagine to a serine (N/S)
and editing of the C site generates an aspartate. The
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Surgeons known to be edited. In the rodent and human brain,
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receptor mRNAs are expressed (Burns et al., 1997; Nis-
wender et al., 1999), and the significance of this editing
in vivo is still unknown. However, studies on transfectedSummary
cells that express individual 5-HT2C receptor isoforms
indicate that certain editing combinations alter the abil-Five adenosines within the coding sequence of the
serotonin 2C receptor (5-HT2C) pre-mRNA are con- ity of the receptor to activate phospholipase C (PLC). For
example, receptor isoforms resulting from the editingverted to inosines by RNA editing (named A, B, C (E),
C, and D sites). In human prefrontal cortex (PFC), the combinations A(B)CD, A(B)CC, and A(B)CCD (the VSV,
VGI, and VGV isoforms, respectively) show significantlymost abundant 5-HT2C mRNA sequences result from
editing at the A site, or from the editing combinations less PLC activation than non-edited 5-HT2C receptors
(Burns et al., 1997; Niswender et al., 1999; Fitzgerald etACC, ABCD, and ABD. In suicide victims with a history
of major depression, C site editing is significantly in- al., 1999; Wang et al., 2000b). Altogether, these studies
suggest that, regardless of the final editing combination,creased, D site editing is significantly decreased, and
the C site shows a trend toward increased editing. editing at the C and C sites most efficiently downregu-
lates the activity of 5-HT2C receptors (Wang et al.,Treatment of mice with the antidepressant drug fluox-
etine (Prozac) causes changes in C, C, and D site 2000b).
In this report, we examine the expression of 5-HT2Cediting that are exactly opposite to those seen in sui-
cide victims. Thus, one outcome of fluoxetine treat- mRNA in the human dorsal prefrontal cortex (PFC).
Moreover, because lower serotonergic activity is thoughtment may be to reverse the abnormalities in 5-HT2C
pre-mRNA editing seen in depressed suicide victims. to be a major contributing factor to suicide risk (Mann,
2000), we further tested whether the expression of dis-
tinctly edited 5-HT2C receptor mRNAs differs in tissuesIntroduction
obtained from depressed suicide victims compared to
healthy controls. Our results indicate significantly differ-The 5-HT2C receptor is widely distributed in the central
nervous system and is thought to play a role in regulating ent 5-HT2C pre-mRNA editing site preferences in brains
of suicide victims. In addition, the changes in editing sitemood, appetite, and sexual behavior (Molineaux et al.,
1989; Roth et al., 1998). In both rodents and humans, preferences detected in suicide victims with a history of
major depression are opposite from changes in corre-5-HT2C pre-mRNA is a substrate for deaminating editing
enzymes that attack five closely spaced adenosine resi- sponding editing site preferences detected in mice
treated chronically with the antidepressant drug fluoxe-dues located within sequences encoding the putative
second intracellular domain of the receptor, a region tine (Prozac). Altogether, these results suggest a role for
5-HT2C pre-mRNA editing in depression. They furtherthought to be of general importance for G protein cou-
pling (Burns et al., 1997; Moro et al., 1993; Scho¨neberg suggest that fluoxetine treatment may reverse the ab-
normalities in 5-HT2C pre-mRNA editing detected inet al., 1995). These editing sites are named (from 5 to
3) A, B, C (E), C, and D (Burns et al., 1997; Niswender suicide victims with major depression.
et al., 1999). Two adenosine deaminases that act on
RNA (ADAR1 and ADAR2) are thought to convert the Results
adenosine (A) residues of these sites to inosines (I)
(Burns et al., 1997; Liu et al., 1999), and results of two Editing of the 5-HT2C Pre-mRNA in the Dorsal
studies on knockout mice suggest a major role of ADAR1 PFC (Brodman Area 9) of Controls
in the editing of the A and B sites and of ADAR2 in the and Depressed Suicide Victims
editing of the C and D sites in vivo (Wang et al., 2000a; Theoretically, editing of the 5-HT2C pre-mRNA could
Higuchi et al., 2000). Because inosine prefers to base generate 32 different mRNA isoforms (25 32; see Table
pair with cytidine, sense-strand cDNA copies contain 1) if all sites are edited independently. Nucleotide se-
guanosines at the position of the inosine. In 5-HT2C quence analysis of 477 cDNA clones generated from
mRNA, such A to G conversions alter the coding poten- prefrontal cortical RNA extracted from tissues of 11 dif-
ferent subjects revealed a total of 23 mRNA isoforms
(22 of which result from RNA editing) that code for 154 Correspondence: schmauss@neuron.cpmc.columbia.edu
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Comparisons Test). In addition, the expression of theTable 1. 5-HT2C mRNA Sequences Resulting from Pre-mRNA
Editing in the Human Prefrontal Cortex A-edited isoform was decreased more than 2-fold (p 
0.004) in this group. The mean percentages of the otherNon-Expressed
two 5-HT2C mRNA isoforms that are common to bothAbundant Isoformsa Rare Isoformsb Sequences
groups (ABCD, ABD) were similar in both groups
Control Brains (n  5)
(Table 2).
25%: ABCCD BCCD
However, as shown in Table 2, only five of the sixACC ABCC BCC
suicide victims exhibited a similarly altered 5-HT2C10%: ABCD BCD
ABCD, A ABC BCD mRNA isoform expression pattern. These are the four
5% to 10%: ABC BC subjects that suffered from a mood disorder and the
AD, NE, ABD, ACD, ACCD ACD BC 18-year-old hispanic male with no documented history
AB CCD
of an Axis I psychiatric illness. In contrast, the sixthAC CC
suicide victim, a 61-year-old white male with a historySuicides (n  6) AC CD
of single major depressive episode (onset at the age of48%: BD
ACC B 60 years) exhibited similar percentages of ACC, ABCD,
10%: C and A site(s)-edited 5-HT2C mRNA isoforms compared
ABCD CD with controls. Moreover, although non-edited tran-
4% to 10%: C
scripts were consistently found in controls (11.7% ABD, A D
1.5%), they were rarely detected in the first five suicide
a Sequences detected in every subject of each of the two diagnostic victims. In the sixth suicide victim, however, the percent-
groups. age of non-edited mRNA isoforms was atypically highb These sequences represent 1% of all 477 sequences analyzed
(27% of 59 sequences analyzed).and 2% in each of the two groups.
Differences were also found for the frequencies of
successful editing at each of the five editing sites (Table
3). In this analysis, the percentage of successful editingdifferent receptor isoforms (Table 1). However, 15 of
was determined by dividing the number of transcriptsthese mRNA isoforms were detected in only a small
edited at A, B, C, C, or D sites (regardless of the finalnumber of subjects (4) and they represent less than
editing combination) by the total number of sequences1% of all sequences. Eight mRNA isoforms (coding for
analyzed for each subject. Table 3 illustrates lower per-seven protein isoforms) were abundantly detected (see
centages of successful editing for the C and C siteTable 1). In controls, these mRNAs represent more than
and higher percentages for D site editing in controls80% of all 5-HT2C mRNA isoforms (of 207 sequences
compared with suicide victims. Consistent with the re-analyzed) and they were consistently detected in all
sults shown in Table 2, the largest differences weresubjects. The isoforms resulting from ABCD, ACC, and
found between controls and five of the six suicide vic-A site(s) editing were most frequently detected. In 270
tims (i.e., the first five suicide victims listed in Table 3),sequences obtained from a matched group of suicide
and this is particularly evident for their frequencies ofvictims, only 4 of the 8 abundant sequences (those re-
C and C site editing. Due to the high percentage ofsulting from editing at the ACC, ABCD, A, and ABD
non-edited 5-HT2C mRNA found in the sixth suicidesite(s)) were found in all samples where they represented
victim (SED), however, the percentage of successful ed-more than 73% of all sequences. However, whereas
iting is either lower (A site) or within the range of controlstranscripts edited at the ACCD, ACD, and AD sites as
(B, C, C, and D sites).well as non-edited (NE) transcripts were consistently
In summary, five of the six suicide victims studiedfound in all controls, they were detected in some, but
here suffered from a mood disorder. Among those, fournot all, suicide victims (see below).
had a major depressive episode and one had a singleFinally, a total of nine possible editing combinations
episode of a late-onset depression at the time of death.(that would encode nine additional protein isoforms)
As summarized in Figure 1, the group of four subjectswere never observed and, as evident from the results
with major depression differs from controls by exhibitingshown in Table 1, these editing site combinations occur
a significantly increased expression of the ACC-editedonly together with A site editing.
mRNA (p 0.01 (ANOVA)) and a significantly decreasedIn addition to differences in the complexity of 5-HT2C
expression of the A-edited isoform (p  0.008) (FiguremRNA isoform expression between controls and suicide
1A). This is due to significantly increased editing at thevictims, significant differences were found in the per-
C site (p  0.05) and a significantly decreased editingcentages of expression of isoforms that are common to
at the D site (p  0.05). Editing at the C site is alsoboth diagnostic groups. Table 2 lists the percentages
increased. This increase, however, does not reach sta-of the eight major prefrontal cortical 5-HT2C mRNA iso-
tistical significance (p  0.08). The percentages of Aforms for each of the five controls and six suicide vic-
and B site editing did not significantly differ betweentims. Although the suicide victims varied with regard to
the two diagnostic groups (Figure 1B). Whereas the re-their psychiatric diagnosis (four suffered from a mood
sults of one additional suicide victim with no docu-disorder (MD), one suffered from a single episode of
mented Axis I diagnosis (50 sequences analyzed) aredepression (SED), and one was not diagnosed with an
similar to those obtained from suicides with a history ofAxis I psychiatric illness (no 5)), the mean percentage of
major depression, the results of another suicide victimthe ACC-edited isoform was 2-fold higher in the suicide
with a history of a single episode of late-onset depres-group compared to controls (p 0.05; one-way analysis
of variance (ANOVA) followed by Tukey-Kramer Multiple sion differ substantially (see Discussion).
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Table 2. Percentages of Major 5-HT2C mRNA Isoforms in Controls and Suicide Victims
Editing Combinations
ACC ABCD A AD NE ABD ACD ACCD
Control 1 22 33 7 4 4 7 11 7
Control 2 32 10 14 7 3 7 3 11
Control 3 38.5 5.8 15.4 9.6 7.7 7.7 3.8 1.7
Control 4 31.4 5.9 11.8 9.8 4 7.8 5.9 4
Control 5 8.2 6.1 10.2 10.2 16.3 4.1 6.1 2
Suicide/MD 1a 61.1 18.5 5.6 3.7 3.7 3.7 0 0
Suicide/MD 2c 51.9 14.8 3.7 0 0 1.7 3.7 3.7
Suicide/MD 3a,b 76.7 6.6 1.7 0 0 3.3 0 0
Suicide/MD 4a 32 10 6 4 8 18 0 2
Suicide 5a 46 14 4 4 0 10 0 0
Suicide/SED 6d 20.7 10.3 8.6 1.7 27 10.3 8.6 0
MD: mood disorder, SED: single episode of late-onset depression, NE: non-edited.
a No documented antidepressant medication during lifetime;
b diazepam (5 mg/day) during the 3 months prior to suicide.
c Low-dose SSRI-treatment (sertraline; 50 mg/day) within 3 months of suicide that terminated before suicide; no antidepressant treatment at
any other time of life.
d Medium-dose SSRI-treatment (sertraline; 100 mg/day) combined first with the tricyclic antidepressant nortriptyline (dose not documented)
ending 3 weeks before suicide, followed by a combination treatment with the monoamine-reuptake blocker venlafaxine (280 mg/day), a
benzodiazepine (alprazolam; 2 mg/day), and a neuroleptic drug (perphenazine; 20 mg/day) that terminated 2 days before suicide; no antidepres-
sant medication at any other time of life.
Cytoplasmic 5-HT2C mRNA Levels cycles. These data suggest that the levels of 5-HT2C
mRNA do not differ between the two groups (or thatIt is possible that differences in 5-HT2C pre-mRNA edit-
ing are due to differences in the ratios of deaminating differences in editing lead to different mRNA expression
levels).enzyme and the RNA substrate. We therefore tested
whether the levels of 5-HT2C mRNA expressed in the Another relevant question is whether the samples dif-
fer in their ratios of full-length and truncated 5-HT2Chuman PFC differ between the groups of controls and
suicides. Because conventional measurements of corti- mRNA. The truncated 5-HT2C mRNA results from cleav-
age of an alternative 5 splice site located 11 nucleotidescal 5-HT2C mRNA levels (Northern blotting or RNase
protection assays) are not sensitive enough to reliably upstream of the first editing site (i.e., alternative splicing
deletes the editing sequence; Canton et al., 1996). How-detect the very low abundant mRNA (see Julius et al.,
1988), we performed exponential RT-PCR experiments ever, none of the prefrontal cortical RNAs, regardless
of whether they are derived from controls or suicideto compare with Southern blots the lowest number of
PCR cycles needed to detect 5-HT2C amplification victims, contained the truncated 5-HT2C mRNA that is,
for example, abundantly expressed in the choroidproducts (see Experimental Procedures). As shown in
Figure 2, whereas 0.1 ng and 10 pg of plasmid DNA plexus. Representative results of a 35 cycle RT-PCR
experiment are shown in Figure 3.encoding the 5-HT2C receptor led to detectable 5-HT2C
amplification products after only 10 and 15 cycles of
PCR, respectively, prefrontal cortical cDNA templates 5-HT2C Pre-mRNA Editing in the Forebrain
of all controls and the first five suicide victims analyzed of Fluoxetine-Treated Mice
in Tables 2 and 3 required 20 cycles of PCR to yield It is possible that the different editing site preferences
spurious amounts of 5-HT2C cDNA. Moreover, in all of detected in depressed suicide victims are a conse-
these samples, the PCR reaction was saturated after 30 quence of long-term antidepressant drug treatment.
However, as summarized in Table 2, four of six suicide
victims had no documented history of antidepressant
Table 3. Percentages of Successful Editing at the Five Editing Sites
treatment during their lifetime, one suicide victim took
Editing Sites a low dose of the serotonin-selective reuptake inhibitor
(SSRI) sertraline during the last three months prior toA B C C D
suicide, and the subject with the late onset depressionControl 1 96.5 44.5 29.3 77.8 63.0
took a number of powerful antidepressants combinedControl 2 96.5 25.0 46.4 64.3 42.9
with a neuroleptic drug and a benzodiazepine duringControl 3 83.0 17.3 38.5 55.8 32.7
Control 4 86.3 23.1 45.1 56.7 49.0 his last 3 months of life (see Table 2). Because it is often
Control 5 59.2 22.5 22.5 34.7 53.1 difficult to test the impact of various drug treatment
Suicide/MD 1 93.0 20.0 63.0 83.0 28.0 histories on long-term alterations of neurotransmitter
Suicide/MD 2 93.0 30.0 63.0 89.0 30.0 receptor expression and function with studies on post-
Suicide/MD 3 93.0 13.3 83.3 93.0 13.3 mortem tissues, we examined the editing of 5-HT2C
Suicide/MD 4 80.0 50.0 42.0 56.0 38.0
pre-mRNA in forebrain neocortical tissues of drug-naiveSuicide 5 90.0 42.0 54.0 70.0 34.0
129Sv mice and compared these results to correspond-Suicide/SED 6 69.5 28.8 25.4 44.1 35.6
ing ones obtained from mice treated for either 3 or 28
MD: mood disorder, SED: single episode of late-onset depression.
days with the widely prescribed antidepressant drug of
Neuron
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Figure 1. Expression of 5-HT2C mRNA Isoforms in the Dorsal Pre-
frontal Cortex of Controls and Suicide Victims with a History of a
Mood Disorder
(A) shows comparison of the percentages of major edited 5-HT2C
mRNA isoforms. Mean  SEM of determinations made in groups of
five controls and the four suicide victims marked “MD” in Table 2.
Controls: white bars, suicides: gray bars. There are no significant
differences between subjects of the same group. *p  0.01; **p 
Figure 2. Expression Levels of 5-HT2C mRNA in the Prefrontal0.008; controls compared to depressed suicides (ANOVA). (B) shows
Cortexpercentage of successful editing at the five editing sites. Mean 
Southern blot of exponential RT-PCR amplification of cDNA encod-SEM of editing frequencies of controls (white bars) and depressed
ing a 270 nt long sequence of 5-HT2C mRNA sequence containingsuicide victims (gray bars). *p  0.05 (controls compared to de-
the edited region is shown. Aliquots of the PCR reactions werepressed suicides).
removed after 10, 15, 20, 25, 30, and 35 cycles of amplification. For
comparison, PCR amplifications of 0.1 and 0.01 ng of plasmid DNA
encoding the full-length 5-HT2C receptor are shown on top. Blots
the SSRI class, fluoxetine (Prozac). Nucleotide se- were exposed to film for 3 hr. For each tissue sample, the PMI is
indicated in parenthesis. C: controls, S/D: suicides.quence analysis of 674 cDNA clones generated from
forebrain neocortical RNA extracted from both drug-
naive and fluoxetine-treated mice revealed that the ma-
Editing at the C site is also decreased. This decrease,jority of 5-HT2C mRNAs are edited. The isoforms re-
however, does not reach statistical significance (p sulting from editing of the ABD and ABCD sites are
0.08).most frequently detected. In nontreated and fluoxetine-
In summary, the changes in C, C, and D site editingtreated mice, similar percentages of the ABCD-edited
resulting from long-term fluoxetine treatment are the5-HT2C mRNA isoform were found. However, as shown
opposite of those detected in the suicide victims within Figure 4A, compared to nontreated mice, mice treated
a history of major depression. Similar to the approachwith fluoxetine for 28 days express a larger percentage
taken in Figure 2, we also tested with exponential RT-of ABD-edited mRNA isoform (p  0.068; one-way ana-
PCR experiments whether a 3 or 28 day treatment withlysis of variance followed by Tukey-Kramer Multiple
Prozac alters cytoplasmic expression levels of 5-HT2CComparisons Test). Figure 4B further illustrates that flu-
mRNA. No differences were found between nontreatedoxetine treatment leads to changes in editing site prefer-
and fluoxetine-treated mice (not shown).ences. Mice treated with fluoxetine for 3 days exhibit a
significant decrease in C site editing (p  0.05) and
none of the 5-HT2C mRNA sequences expressed in mice Discussion
treated with this drug for 28 days are edited at this site.
Moreover, a prolonged fluoxetine treatment (28 days) Three abundant 5-HT2C mRNA isoforms expressed in
the PFC differ in their relative expression in brains ofleads to a significant increase in D site editing (p 0.05).
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decreased editing of the D site. Our data suggest that,
despite the differences in the editing site preferences,
5-HT2C mRNA levels do not differ between the two diag-
nostic groups. Whether the activities of editing enzymes
differ in the PFC of these groups remains to be deter-
mined.
Our sequence analysis was performed on PCR-ampli-
Figure 3. Expression of Full-Length and Truncated 5-HT2C mRNA
fied cDNAs, an experimental condition that could poten-in the Prefrontal Cortex (PFC) and the Choroid Plexus (CP)
tially distort the relative ratios of differently edited iso-Shown is a Southern blot of RT-PCR amplification of cDNA encoding
forms. However, we found that, for each individuala 270 nt long sequence of the full-length 5-HT2C receptor and a
subject, the analysis of a minimum of 30 cDNA clones175 nt long fragment of the alternatively spliced (5-HT2Ctr) mRNA.
An overexposed film is shown here to illustrate that, in contrast to derived from a single bacterial transformation provides
the abundant expression of 5-HT2Ctr in the CP, this mRNA variant a reliable estimate of the relative ratios of major edited
is not detected in the PFC. SD: suicide/depression, C: controls, S: isoforms that is closely replicable in several independent
suicide.
experiments. This indicates that, similar to the study of
Sommer et al. (1991), the PCR amplification is not sub-
ject to larger variations from experiment to experimentcontrols and depressed suicide victims. In suicides, a
but rather revealing the relative abundance of majorsignificantly increased expression of the ACC-edited
edited isoforms present in the input samples. However,receptor mRNA (encoding the VGI isoform) is accompa-
the complexity of expression of differently editednied by a significantly decreased expression of the
5-HT2C mRNA isoforms necessitated the analysis of aA-edited mRNA. Moreover, non-edited mRNA is com-
large number of RNA sequences for each subject andmonly found in controls but this mRNA isoform is only
thus, in practical terms, limited the number of subjectsrarely detected in suicides that suffered from major de-
studied in this report. Two recent studies took less labo-pression. These differences in editing pattern are due
rious approaches to characterize the editing of theto significantly increased C site editing, a trend toward
significantly increased C site editing, and a significantly 5-HT2C pre-mRNA in the PFC of controls and schizo-
Figure 4. Expression of 5-HT2C mRNA Iso-
forms in the Forebrain Neocortex of 129Sv
Mice
(A) shows comparison of the percentages of
major edited 5-HT2C mRNA isoforms ex-
pressed in nontreated and fluoxetine-treated
mice. Mean  SEM of determinations made
in four animals per treatment group. For each
animal, 51 to 73 5-HT2C cDNA clones ob-
tained from a single bacterial transformation
were analyzed. (B) Percentage of successful
editing at the five editing sites. Mean  SEM
of editing frequencies of nontreated and fluox-
etine-treated mice. (*p 0.05 and **p 0.01.)
White bars: controls, light gray bars: 3 day
fluoxetine treatment, dark gray bars: 28 day
fluoxetine treatment.
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phrenic patients. One involved a primer-extension anal- the fully functional non-edited and A site-edited mRNA,
has functional consequences under conditions of aysis of the editing region in 5-HT2C mRNAs, an approach
that allowed a comparison between groups composed compromised serotonergic neurotransmission.
The brain samples analyzed in this study were wellof much larger numbers of subjects (Niswender et al.,
2001) at the expense of conducting a less sensitive and matched with regard to age, sex, ethnic background,
and postmortem interval. Although each diagnosticincomplete analysis of the five editing sites found in
5-HT2C pre-mRNA. The other study (Sodhi et al., 2001) group was composed of subjects with diverse ethnic
backgrounds and although both groups were notused a very small number of nucleotide sequences (10
per individual) to characterize 5-HTC pre-mRNA editing. matched for other parameters such as health, nutrition,
socioeconomic status, jobs, etc., the frequency distribu-It is thus likely that the different results obtained in these
two studies relate to the insufficiency of both ap- tion of major edited 5-HT2C mRNA isoforms as well as
the percentages of editing of each of the five editingproaches to characterize the editing of 5-HT2C pre-
mRNA in the PFC. sites did not significantly differ between subjects of the
control group or the group of suicides with a history ofPrevious studies that characterized the functional
properties of recombinant non-edited, partially edited, major depression. Suicide, however, often occurs in the
context of a psychiatric illness and is associated mostand fully edited isoforms expressed singly in transfected
cells have shown that editing combinations ABCD and often with major depression (Mann, 2000). Therefore,
postmortem studies on brains of suicide victims oftenABCCD differ from non-edited and other partially edited
isoforms in their reduced ability to activate G protein leave unresolved whether any of the observed biochemi-
cal abnormalities are due to the presence of major de-in response to agonist stimulation (Burns et al., 1997;
Niswender et al., 1999; Fitzgerald et al., 1999). In earlier pression or whether they reflect abnormalities that char-
acterize suicidal behavior. In the present study, onlystudies, this compromised ability to activate G protein
was found to be largest only for the fully edited isoform five of six suicide victims suffered from depression. The
remaining subjects committed suicide at the age of 18(ABCCD) (Niswender et al., 1999), which is rarely found
in the PFC (see Table 1). However, as recently shown in the context of an antisocial personality disorder, a
condition characterized by an elevated suicide rate and(Wang et al., 2000b), editing at the CC sites (as it occurs
in the ACC-edited isoform) is sufficient to achieve maxi- impulsive aggression. The latter trait is associated with
impaired serotonergic function and a predisposition tomum downregulation of receptor activity. This phenom-
enon is most apparent when EC50 concentrations of suicidal behavior (Mann, 2000) and the results obtained
from this suicide victim are very similar to those found forweak and partial agonists are compared for their ability
to stimulate PLC upon binding to non-edited and CC the suicide victims that suffered from major depression.
Thus, to further evaluate the role of major depression insites-edited receptor isoforms whose responses to
maximum stimulation with serotonin (5-HT) do not differ the abnormalities described here, future studies should
test for differences between nondepressed suicides and(Niswender et al., 1999; Wang et al., 2000b). The present
data therefore suggest an overall decreased 5-HT2C suicide victims with a history of major depression.
Differences in 5-HT2C pre-mRNA editing site prefer-receptor activity in the PFC of suicide victims with a
history of major depression. However, it is evident from ences could also exist between different diagnostic sub-
classifications or different courses of depressive illness.the results shown in Table 1 that a variety of differently
edited 5-HT2C receptor isoforms is expressed in the The results obtained from an additional 61-year-old sui-
cide victim who suffered from a single (documented)PFC. Thus, the net outcome of activating this mixed
population of receptors in vivo is not known. It is also episode of depression are not only different from con-
trols but also from the other suicide victims. In fact, thisclear that editing of 5-HT2C pre-mRNA does not lead
to drastic changes in receptor function. The rather subtle subject expressed an abnormally high percentage of
non-edited 5-HT2C mRNA. This preliminary observationfunctional changes that are reflected in the increased
EC50 concentration of full or partial 5-HT2C receptor suggests that, in addition to testing for differences in
5-HT2C pre-mRNA editing between nondepressed andagonists support the recent hypothesis that this editing,
like the majority of site-specific A to I editing of neuronal depressed suicide victims, more information is needed
to evaluate whether different courses of depressive ill-transcripts that have thus far been identified, enable
a “fine-tuning” of the activity of distinct physiological ness (age of onset, number of depressive episodes) are
associated with different 5-HT2C pre-mRNA editing siteprocesses (see Seeburg, 2000). Hence, one would pre-
dict that differences in 5-HT2C receptor activity that preferences.
Finally, a major concern in all studies that attempt toresult from the alterations in editing described here
would become most apparent when serotonergic neuro- correlate mood and schizophrenic disorders with
changes in the expression and/or function of neuro-transmission is reduced. In this regard, it is of interest
to note that a study on nondepressed and depressed transmitter receptors is whether the observed molecular
abnormalities are related to pharmacological interven-suicide victims found a widespread reduction in the ex-
pression of serotonin transporter radioligand binding tions that (directly or indirectly) target these receptors.
Clearly, the question whether the altered editing seensites only in the PFC of depressed suicide victims (Mann
et al., 2000). Thus, although the in vivo significance of in brains of depressed suicide victims is a consequence
of antidepressant drug treatment that is known to alterthe altered editing described here is still unclear and
although the actual synaptic concentration of 5-HT in serotoninergic neurotransmission is of particular rele-
vance. In the present study, however, four of six suicidethe PFC is also not known, the present data suggest that
the increased expression of the ACC-edited isoform, victims had no lifetime history of antidepressant treat-
ment. One other subject took a low dose of sertralinewhich occurs together with a decreased expression of
5-HT2C Receptor Pre-mRNA Editing in Depression
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Experimental Proceduresfor a period of 3 months and terminated the drug prior
to suicide. The sixth subject (who suffered from a single,
Brain Tissueslate-onset depressive episode) was treated with a com-
Prefrontal cortical brain samples were obtained from autopsy mate-
plex combination of antidepressant, neuroleptic, and rial derived from the brain tissue collection of the New York State
anxiolytic drugs for the last 3 months of his life and Psychiatric Institute and Columbia University. Dorsal prefrontal cor-
tical tissues (Brodman area 9) from five controls (males, mean age:this treatment terminated only 2 days before suicide.
40.8 10.1 years (mean SD); age range: 18 to 63 years; postmor-Because it is difficult to test the impact of various drug
tem interval (PMI): 19.1  1.5 hr; ethnic background: white (n  2),treatment histories on long-term alterations of neuro-
black (n  1), hispanic (n  2)) were studied in parallel to a matchedtransmitter receptor expression and function with stud-
group of six suicide victims (males, mean age: 44.2  8.9 years;
ies on postmortem tissues, we have begun to test for age range: 18 to 64 years; PMI: 16.6  1.9 hr; ethnic background:
changes in 5-HT2C pre-mRNA editing in the forebrain white (n  3), black (n  1), hispanic (n  2)). All subjects died
without a prolonged agonal period. Cause of death was determinedneocortex of mice treated chronically with antidepres-
by the coroner or medical examiner. Postmortem toxicological anal-sant drugs. Interestingly, our studies on mice treated
ysis, performed on all cases, ruled out recent consumption of alcoholchronically with the most widely prescribed antidepres-
and, with one exception, psychotropic medication or other sub-sant SSRI fluoxetine revealed drug-induced alterations
stances of abuse. (One suicide victim consumed cannabis prior to
in the editing of the 5-HT2C receptor that are opposite death.) The classification of suicide victims required evidence of
from those detected in suicide victims with a history intent and a self-inflicted fatal act. Cases of uncertain causes of
death were excluded. Psychological autopsies (performed on allof major depression. These results suggest that one
cases) and reviews of hospital records revealed that four of the sixtherapeutic outcome of fluoxetine treatment is a reversal
suicide victims suffered from major depression (one of whom wasof the abnormalities in 5-HT2C pre-mRNA editing de-
also diagnosed with a schizoid personality disorder), and one suf-scribed here. This is not inconsistent with the results
fered from a single episode of late-onset depression. The remaining
obtained from a suicide victim who was treated with the suicide victim died at the age of 18 with no Axis I psychiatric diagno-
less potent SSRI sertraline because this subject took a sis but exhibited symptoms of an antisocial personality. These diag-
noses, verified by a psychiatrist, were made according to DSM-IIIlow dose (50 mg/day) that is typically administered only
criteria and validated for Axis I and Axis II disorders using the Struc-at the very beginning of the treatment and thus may have
tural Clinical Interview I and II for diagnosis, the Suicide Historybeen too low to affect the 5-HT2C pre-mRNA pattern.
Form (Columbia University, New York) for past suicidal acts, theMoreover, the subject terminated the medication before
Brown Goodwin Aggression History Scale for lifetime aggression,
suicide. However, it remains possible that the very dis- and a checklist for demographic data and other clinical details. All
tinct editing pattern of the other subject who suffered control subjects had no history of psychiatric disorders and died
from causes other than suicide.from a late-onset depression resulted from his complex
In addition, one tissue sample of the choroid plexus of white malepsychopharmacological treatment history and future
suicide victim (age: 26 years; PMI: 30 hr) with a history of majorstudies should investigate whether, in addition to SSRIs,
depression was obtained.other types of antidepressants drugs or even anxiolytic,
sedative, or neuroleptic drugs decrease site-specific ed-
RNA Extraction, Generation of 5-HT2C cDNA, Nucleotideiting of 5-HT2C pre-mRNA in the PFC.
Sequence Analysis, Exponential RT-PCRIn any case, the data of both the human and mouse
RNA was extracted from 0.4 g of fresh-frozen autopsy material usingstudies suggest that the editing of 5-HT2C pre-mRNA
guanidine/cesium chloride ultracentrifugation. Ten micrograms of
is regulated in a serotonin-dependent manner. This can total RNA was used as a template for first-strand cDNA synthesis
now be tested with mice depleted of the neurotransmit- that was primed with an oligo-dT primer. 5-HT2C cDNA was ampli-
fied by polymerase chain reaction (PCR) specified by the primerster serotonin.
5-CTG GCC ACT ACC TAG ATA-3 and 5-GTC GTT GAG CAC GCA
CGT-3. The amplified sequence comprises nucleotides 355 to 635
of the human 5-HT2C mRNA (Saltzman et al., 1991) and containsConclusions
the edited region.
The present study describes alterations in 5-HT2C pre- 5-HT2C cDNA was cloned into the plasmid vector pCRII (In-
mRNA editing site preferences in the dorsal PFC of de- vitrogen, Carlsbad, CA). Recombinant plasmids were transformed
into bacteria and plasmid DNA was recovered from single bacterialpressed suicide victims. Previous studies have identi-
colonies for cDNA sequence analysis using the dideoxy-chain-ter-fied abnormally increased alternative splicing activities
mination method in conjunction with 35S-dATP and the primer 5-in brains of patients with schizophrenia which alter the
GTA GCA CAG CGT CCA TCA-3. For two subjects per diagnosticexpression of the dopamine D3 (Schmauss, 1996) and group, 27 to 30 5-HT2C nucleotide sequences were analyzed and
GABAA receptors (Huntsman et al., 1998). In all cases for all other subjects per group, 50 to 59 sequences were obtained.
presently identified, the affected mRNAs encode neuro- There was no significant change in the frequency distribution of
major edited isoforms determined in 27 or 59 sequences. For eachtransmitter receptors that are targets (directly or indi-
subject, all sequences were derived from plasmid DNAs recoveredrectly) for drugs with antipsychotic potencies: neuro-
from a single bacterial transformation.leptic drugs (D3 receptor), benzodiazepines (GABAA For exponential RT-PCR experiments, equal amounts of oligo-
receptors), and antidepressants (5-HT2C receptor). Fur- dT-primed cDNA generated from 10 g of total RNA of ten subjects
thermore, in all cases, altered alternative splicing or edit- was added to a mastermix of a PCR buffer containing the four
ing activities lead to the expression of mRNAs encoding deoxynucleotide triphosphates, the 5 and 3PCR primers described
above, and Taq polymerase (Stratagene; La Jolla, CA). The PCReither nonfunctional (D3) or less functional (GABAA,
reaction was terminated after 10, 15, 20, 25, 30, and 35 cycles of5-HT2C) receptors. This suggests that the posttran-
amplification by removing an aliquot of the PCR reaction at eachscriptional regulation of gene expression plays a role in
time point. All aliquots were loaded onto a single 1% agarose gel and
modulating the expression of distinct neurotransmitter transferred to a membrane that was probed with a 32P-radiolabeled
receptors in brains of patients with major psychiatric cDNA encoding a HindIII restriction fragment of the 5 portion of
the open reading frame of the human 5-HT2C cDNA.disorders.
Neuron
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Drug Treatment of 129Sv Mice and Analysis of 5-HT2C mRNA heim, S., Kelly, T.M., Dwork, A.J., and Arango, V. (2000). A serotonin
transporter gene promotor polymorphism (5-HTTLPR) and prefron-All procedures involving animals were carried out in accordance
with the National Institutes of Health Guide for the Care and Use of tal cortical binding in major depression and suicide. Arch. Gen.
Psychiat. 57, 729–738.Laboratory Animals and approved by the Institutional Animal Care
and Use Committee at Columbia University. Fluoxetine HCl was Molineaux, S.M., Jessel, T.M., Axel, R., and Julius, D. (1989). 5-HT1c
administered to two groups of adult male 129Sv mice (postnatal receptor is a prominent serotonin receptor subtype in the central
age P60 to P90) with the drinking water. One group, composed of nervous system. Proc. Natl. Acad. Sci. USA 86, 6793–6797.
four group-housed animals, received fluoxetine treatment for 3 days. Moro, O., Lameh, J., Hogger, P., and Sadee, W. (1993). Hydrophobic
The other group, also composed of four group-housed animals, amino acid in the i2 loop plays a key role in receptor G-protein
received fluoxetine treatment for a period of 28 days. Four additional coupling. J. Biol. Chem. 268, 22273–22276.
mice received regular drinking water (controls). During the first week
Niswender, C., Copeland, S.C., Herrik-Davis, K., Emeson, R.B., andof fluoxetine treatment, mice drank 5 ml of water/24 hr and thus
Sanders-Bush, E. (1999). RNA editing of the human serotoninconsumed 5 mg/kg of the drug. In the second and third weeks of
5-hydroxytryptamine 2C receptor silences constitutive activity. J.treatment, their water intake increased to 7 ml/24 hr (7 mg/kg of
Biol. Chem. 274, 9472–9478.the drug) and this was accompanied by a 10% to 12% increase
Niswender, C.M., Herrick-Davis, K., Dilley, G., Meltzer, H.Y., Over-in body weight and an increased spontaneous locomotor activity.
holser, J.C., Stockmeier, C.A., Emeson, R.B., and Sanders-Bush,During the fourth week of treatment, we increased the drug dosage
E. (2001). RNA editing of the human serotonin 5-HT2C receptor:to 10 mg/kg/24 hr. At the end of the treatment, animals were killed
Alterations in suicide and implications for serotonergic pharmacol-by decapitation and their forebrain neocortex was dissected from
ogy. Neuropsychopharmacol. 24, 478–491.both hemispheres. RNA extraction, PCR amplification (using the
mouse-specific primer pair: 5-TATTTGTGCCCCGTCTG-3 and 5- Roth, B.L., Willins, D.L., Kristiansen, K., and Kroeze, W.K. (1998).
GAGCACGCAGGTAGTATT-3), cloning, and nucleotide sequencing 5-hydroxytryptamine2-family receptors (5-hydroxytryptamine2A,
(using the mouse specific primer 5-TATTTGTGCCCCGTCTG-3) 5-hydroxytryptamine2B, 5-hydroxytryptamine2C): Where structure
were performed as described above. For each of the 12 mice, 51 meets function. Pharmacol. Ther. 79, 231–257.
to 73 cDNAs recovered from a single bacterial transformation were Saltzman, A.G., Morse, B., Whiteman, M.M., Ivanshchenko, Y., Jaye,
sequenced. M., and Felder, S. (1991). Cloning of the human serotonin 5-HT2
and 5-HT1C receptor subtypes. Biochem. Biophys. Res. Comm.
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